Opko Health, Inc. (OPK)

betcat (< 20) Submitted: 10/30/07 7:38 PM : Start Price: $4.20 OPK Score: -39.43

good product in the pipeline

Report this Post Replies: 0 | Reply | Permalink

stuartcreekfarms (73.44) Submitted: 2/24/08 12:30 PM : Start Price: $2.72 OPK Score: -27.01

OPK has had excellent results in a phase 2 trial for its drug that silences the gene for macular degeneration.
The drug is now in a phase 3 trial.
Company is being headed by Dr.Phil Frost, who successfully ran both Key Pharmaceutical and IVAX

Report this Post Replies: 0 | Reply | Permalink

msamet1 (98.34) Submitted: 4/18/08 12:10 PM : Start Price: $1.71 OPK Score: 15.21

Management knows how to niche and leverage portfolio. IVAX is an example of previous development activities.

Report this Post Replies: 0 | Reply | Permalink

bluedome (50.34) Submitted: 5/14/08 9:11 PM : Start Price: $2.28 OPK Score: -10.26

technical


15% up today


maybe someone knows something?

Report this Post Replies: 0 | Reply | Permalink

timdoc1 (73.38) Submitted: 5/18/08 11:27 AM : Start Price: $2.41 OPK Score: -13.56

Phil Frost is the force behind this company.
He's a doctor, who just happened to have made billions for himself and others with drug companies.

Google and read about him, and if you think you're smarter than he is, don't buy this company, if you thi...

Report this Post Replies: 1 | Reply | Permalink

watrstocks (< 20) Submitted: 6/04/08 6:28 PM : Start Price: $1.98 OPK Score: 0.32

Good news bout product

Report this Post Replies: 0 | Reply | Permalink

MoneyForHire (64.59) Submitted: 7/09/08 9:53 AM : Start Price: $1.53 OPK Score: 17.48

Its going to be a few years until we see major gains in this stock, but when we do, expect them to be significant.

Report this Post Replies: 0 | Reply | Permalink

nearo (< 20) Submitted: 8/01/08 10:24 AM : Start Price: $1.82 OPK Score: 1.01

Currently consuming lots of cash with very little sales to offset AP or debt obligations. Will likely need to sell more equity to buy time before they can start making money. Looks very risky over the next several months.....

Report this Post Replies: 0 | Reply | Permalink

zzlangerhans (95.24) Submitted: 8/15/08 2:12 AM : Start Price: $1.85 OPK Score: -0.72

The huge float makes Opko seem deceptively cheap. But 350M for a completely unproven siRNA therapy with a scam artist like Philip Frost at the wheel is definitely not cheap. Why anyone entrusts this guy with an investment after disasters like Protali...

Report this Post Replies: 0 | Reply | Permalink